EXCEL DIAGNOSTICS LTD
NPI 1811004781
Physiological Laboratory in Houston, TX

Active since August 24, 2006
9701 RICHMOND AVE STE 122, HOUSTON, TX 77042(713) 781-6200 Get Directions Write a Review

NPPES record last updated: February 23, 2026. Verified against the NPPES registry weekly; last sync: July 19, 2026.

About Excel Diagnostics Ltd NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

EXCEL DIAGNOSTICS LTD (NPI 1811004781), doing business as Excel Diagnostics & Nuclear Oncology Center, is a healthcare organization registered as a physiological laboratory in Houston, Texas and active in the NPI registry since August 2006. The organization lists Ebrahim S. Delpassand, Medical Director, President & Ceo, as its authorized official.

NPPES Registry Identity

NPI1811004781
Entity TypeOrganization
Primary Taxonomy293D00000X
Legal Business NameEXCEL DIAGNOSTICS LTD
Location Address9701 RICHMOND AVE STE 122Houston, TX 77042-4622
Mailing AddressPo Box 421413Houston, TX 77242-1413
Organization SubpartNo
Authorized OfficialEbrahim S. DelpassandMedical Director, President & Ceo · (713) 781-6200
Enumeration DateAugust 24, 2006
Last NPPES UpdateFebruary 23, 2026
NPPES CertifiedFebruary 23, 2026
NPI 1811004781 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses 2

Primary SpecialtyPhysiological LaboratoryLaboratories
Taxonomy Code293D00000X
Definition

A laboratory that operates independently of a hospital and physician's office to furnish physiological diagnostic services (e.g. EEG's , EKG's, scans, etc.). Facilities offering ONLY physiological services are not certified as independent laboratories. If an independent laboratory offers physiological services IN ADDITION to clinical laboratory services, they are surveyed only for compliance with the clinical laboratory regulations because there are no health and safety regulations for physiological services.

Also ListedClinic/Center · RadiologyTaxonomy 261QR0200X
9701 RICHMOND AVE STE 122, Houston, TX 77042

Other Names 1

Doing Business AsExcel Diagnostics & Nuclear Oncology Center

Other Identifiers 1

Medicaid162587301TX

Accepted Insurance

Areas of Expertise CMS Part B claims 16

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Piflufolastat f-18, diagnostic, 1 millicurie A9595
Piflufolastat F-18 is a radioactive diagnostic agent used in PET scans. It helps visualize certain cells in your body, aiding doctors in diagnosing specific conditions. This service involves injecting 1 millicurie of the agent into your body.
245 services27 patients
Nuclear medicine study limited area with ct scan 78814
A nuclear medicine study with a limited area CT scan is a diagnostic procedure. A small amount of radioactive substance is injected into your body, which helps create detailed images of a specific area. The CT scan further enhances these images, providing clearer, more precise results.
91 services91 patients
Florbetapir f18, diagnostic, per study dose, up to 10 millicuries A9586
Florbetapir F18 is a radioactive diagnostic agent used in PET scans to detect beta-amyloid plaques in the brain, which are associated with Alzheimer's disease. This specific service refers to a single study dose of up to 10 millicuries.
91 services91 patients
Injection, regadenoson, 0.1 mg J2785
Regadenoson injection, 0.1 mg, is a medication used to help visualize the heart during a stress test. It works by increasing blood flow in the arteries of the heart. It's injected into a vein and is generally well-tolerated.
90 services24 patients
Nuclear medicine study from skull base to mid-thigh with ct scan 78815
A nuclear medicine study from skull base to mid-thigh with a CT scan involves using a small amount of radioactive material and CT imaging to examine body tissues and organs. This helps detect any abnormalities by providing detailed images of the body's internal structure.
74 services64 patients
Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie A9596
Gallium Ga-68 Gozetotide (Illuccix) is a diagnostic procedure using a radioactive tracer. It helps visualize certain types of tumors in your body by injecting a small amount of radioactive material. This is safe and aids doctors in accurate diagnosis and treatment planning.
65 services13 patients

Other Providers at the Same Location NPPES 3

Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.

Clinic/Center (Radiology)
9701 RICHMOND AVE STE 122
HOUSTON, TX 77042
Obstetrics & Gynecology (Gynecology)
9701 RICHMOND AVE STE 122
HOUSTON, TX 77042
Specialist
9701 RICHMOND AVE STE 122
HOUSTON, TX 77042

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Excel Diagnostics Ltd's NPI number?

The NPI number for Excel Diagnostics Ltd is 1811004781. It was assigned to this organization in the NPPES registry on August 24, 2006. The provider is doing business as Excel Diagnostics & Nuclear Oncology Center.

Where is Excel Diagnostics Ltd located?

Excel Diagnostics Ltd is located at 9701 Richmond Ave Ste 122, Houston, TX 77042. The listed phone number is (713) 781-6200.

What is Excel Diagnostics Ltd's specialty?

The primary specialty registered for this NPI is Physiological Laboratory with taxonomy code 293D00000X.

What insurance does Excel Diagnostics Ltd accept?

Health plans from Blue Cross and Blue Shield of Texas, Community Health Choice, Molina Healthcare, Oscar Insurance Company and UnitedHealthcare and 1 other insurer list Excel Diagnostics Ltd as in-network in at least one marketplace plan. Coverage varies by plan and year; verify with the insurer or the provider before a visit.

When was this NPI record last updated?

The NPPES record for Excel Diagnostics Ltd was last updated on February 23, 2026. NPI Profile syncs with the weekly NPPES data releases published by CMS.